Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harbin High-Tech Baitian'Er Pharmaceutical Group Co., Ltd. is a Chinese pharmaceutical company headquartered in Harbin, Heilongjiang Province. It operates as a key subsidiary of Xiangcai Co., Ltd., following the corporate restructuring of the Harbin High-Tech Group. The company is primarily engaged in the research, development, and large-scale manufacturing of chemical synthetic drugs and traditional Chinese medicine preparations. Its extensive product catalog includes treatments for cardiovascular diseases, respiratory ailments, and bacterial infections, marketed under the well-known "Baitian'Er" brand. With multiple GMP-certified production lines, the firm supplies various dosage forms, including tablets, capsules, and small-volume injections, to the healthcare sector across China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harbin High-Tech Group Baitian'Er Pharmaceutical.